Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Arcus Biosciences Inc (NY: RCUS ) 14.28 -0.45 (-3.05%) Official Closing Price Updated: 7:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Arcus Biosciences Inc < Previous 1 2 3 4 5 Next > Cracking The Code: Understanding Analyst Reviews For Arcus Biosciences July 08, 2024 Via Benzinga After Disappointing Bladder Cancer Data, Gilead Announces Encouraging Data From Gastric, Colorectal Cancer Studies June 03, 2024 Gilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cancers, showing improved progression-free survival and objective response... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 24, 2024 Via Benzinga RCUS Stock Earnings: Arcus Biosciences Beats EPS, Beats Revenue for Q1 2024 May 08, 2024 RCUS stock results show that Arcus Biosciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Navigating 5 Analyst Ratings For Arcus Biosciences March 25, 2024 Via Benzinga Critical Insights From Arcus Biosciences Analyst Ratings: What You Need To Know February 22, 2024 Via Benzinga Recap: Arcus Biosciences Q4 Earnings February 21, 2024 Via Benzinga Earnings Scheduled For February 21, 2024 February 21, 2024 Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. Via Benzinga Preview: Arcus Biosciences's Earnings February 20, 2024 Via Benzinga Key Takeaways From Arcus Biosciences Analyst Ratings January 30, 2024 Via Benzinga $320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying February 01, 2024 Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday January 30, 2024 We're starting off trading on Tuesday with a look into the biggest pre-market stock movers traders need to keep an eye on today! Via InvestorPlace Pharma Giant Gilead Raises Stake In Cancer-Focused Arcus Biosciences, Stock Soars January 30, 2024 Arcus Biosciences sees a 17.1% surge as Gilead Sciences amends collaboration, investing $320M at $21.00/share. Accelerate joint programs in cancer therapy. Via Benzinga What 9 Analyst Ratings Have To Say About Arcus Biosciences November 08, 2023 Via Benzinga Arcus Biosciences: Q3 Earnings Insights November 07, 2023 Via Benzinga Expert Ratings for Arcus Biosciences October 03, 2023 Via Benzinga Where Arcus Biosciences Stands With Analysts September 12, 2023 Via Benzinga 5 Analysts Have This to Say About Arcus Biosciences August 24, 2023 Via Benzinga Preview: Arcus Biosciences's Earnings August 04, 2023 Via Benzinga Positive News For Gastric Cancers - Gilead/Arcus Biosciences' Combination Cancer Therapy Shows Encouraging Clinical Activity November 07, 2023 Gilead Sciences Inc (NASDAQ: GILD) and Arcus Biosciences Inc (NYSE: RCUS) announced that domvanalimab plus zimberelimab and chemotherapy showed encouraging overall response rate (ORR) and six-month... Via Benzinga Stocks That Hit 52-Week Lows On Thursday October 05, 2023 On Thursday, 369 companies hit new 52-week lows. Via Benzinga Earnings Scheduled For November 7, 2023 November 07, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. Via Benzinga Who Are Other Players Gaining From Roche's Accidental Lung Cancer Data Update August 23, 2023 Earlier today, Roche Holdings AG (OTC: RHHBY) announced that it had been made aware of inadvertent disclosure of the second interim analysis of Phase 3 SKYSCRAPER-01 study, evaluating tiragolumab plus... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session August 23, 2023 Via Benzinga Why Grab Holdings Are Trading Higher By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session August 23, 2023 Gainers AgileThought, Inc. (NASDAQ: AGIL) jumped 85.5% to $0.3941. AgileThought recently posted a loss for the second quarter. Via Benzinga How Roche's Accidental Cancer Update Lifted Iteos And Arcus More Than 30% August 23, 2023 Roche provided an update from its study in lung cancer using an anti-TIGIT drug. Via Investor's Business Daily 12 Health Care Stocks Moving In Wednesday's Pre-Market Session August 23, 2023 Via Benzinga Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket August 23, 2023 Gainers BioNexus Gene Lab Corp. (NASDAQ: BGLC) shares gained 48.5% to $2.05 in pre-market trading after jumping 30% on Tuesday. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday August 23, 2023 It's time for another dive into the biggest pre-market stock movers as we break down all of the biggest news on Wednesday! Via InvestorPlace Urban Outfitters, Toll Brothers And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session August 23, 2023 U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.